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Abstract 
Malignant duodenal neoplasms are relatively rare, and the diagnosis is often delayed 
because of their vague and nonspecific symptoms. We report the case of a 79-year-old 
female who had a medical history of malignant melanoma of the cheek that had initially 
been diagnosed at 53 years of age. Work-up revealed severe stenosis of the duodenum 
caused by a large mass with ulceration at the tip of its mucosal surface. Tumor biopsy led 
to a histological diagnosis of extremely poorly differentiated carcinoma, but it was 
impossible to determine whether the lesion was a primary neoplasm or represented 
secondary involvement. Pancreatoduodenectomy was performed, and the surgical 
specimen showed a protuberant tumor in the nonampullary region of the second portion 
of the duodenum. Final diagnosis of metastatic duodenal melanoma was made by 
immunohistological examination. She is currently alive without recurrence 28 months 
after the surgical treatment. 
 
Introduction 
Malignant duodenal neoplasms are relatively rare, and the most common site of 
occurrence is the periampullary region. Due to nonspecific symptoms, the diagnosis is  
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frequently delayed unless acute complications such as obstruction, massive bleeding or 
perforation develop. We report a case who complained of weakness only. Endoscopy 
revealed a fairly large duodenal mass in the nonampullary region of the second portion of 
the duodenum, but the pathological diagnosis could not be made before surgery, even 
after histological examination of the endoscopic biopsy. 
Case Report 
A 79-year-old woman was admitted to the Department of Cardiovascular Surgery complaining of 
weakness. She had undergone aortic valve replacement surgery three months before because of severe 
aortic valve stenosis. Prior to the aortic valve replacement procedure, esophagogastroduodenoscopy had 
been performed because of the presence of microcytic anemia (hemoglobin level 10.8 g/dl; normal range 
12–16 g/dl), and it had shown entirely normal findings (fig. 1a). When the patient was readmitted, the 
anemia had markedly progressed (hemoglobin level 8.8 g/dl). Duodenoscopy revealed a severe stenosis 
and ulceration at the tip in the second portion of the duodenum despite the absence of any digestive 
complaints. The mucosal surface was highly friable and bled easily (fig. 1b). Biopsy specimens of the 
lesion revealed extremely poorly differentiated carcinoma, and it was impossible to determine whether 
the lesion was primary or metastatic. Computed tomography showed circumferential but asymmetric 
stenosis due to severe parietal thickening in the second portion of the duodenum (fig. 2). This parietal 
thickening extended vertically and measured 26 × 60 mm. Although several periduodenal lymph nodes 
were detected, they were all less than 10 mm in diameter. No other lesions, including dilatation of the 
main pancreatic duct or biliary system, were found, and a primary duodenal cancer was suspected based 
on the above findings. Laboratory studies, including serum CA19-9 and CEA, did not yield any 
abnormal findings except a slight elevation of the LDH level (456 U/l; normal range 190–390 U/l), and 
the patient was referred to our institution. The patient had a history of malignant melanoma (MM) in 
the left cheek diagnosed at 53 years of age, and she had undergone local surgical excision six times for 
relapses over a 10-year period. The subtype of MM diagnosed initially was lentigo maligna. She later 
underwent left lower pulmonary lobectomy for a rapidly growing solitary mass at 71 years of age. 
However, no details regarding the diagnosis of the pulmonary tumor were available when she was 
admitted to our institution. 
At laparotomy, a large, hard tumor was palpable in the second portion of the duodenum, but 
there were no metastatic lesions in other organs, ascites, or intraabdominal seedings. Pancreato-
duodenectomy with en bloc resection of the periduodenal lymph nodes was performed. The resected 
specimen contained a solid mass with a maximum diameter of 5.5 cm in the second portion of the 
duodenum, and the duodenal papilla was completely intact. Histological examination showed a poorly 
differentiated tumor composed of epithelioid cells. The tumor was limited to the submucosal layer and 
muscularis propria and was covered by normal mucosa with no evidence of adenomatous duodenal 
proliferation (fig. 3a). There was cytonuclear atypia with numerous huge nuclei and many mitoses 
(fig. 3b). Immunohistochemical staining of the tumor was strongly positive for HMB45 and Melan-A 
(fig. 3c, d). Tumor cells were negative for epithelial immunochemical markers (cytokeratins, AE-1, 
AE-3, EMA, KL-1) and for common leukocyte antigen (CD45). Consequently, the duodenal tumor was 
confirmed to be metastatic MM. The histological findings in the lung resected 8 years before were 
investigated by requesting sections from the hospital where the resection had been performed, and the 
findings of the duodenal tumor were found to closely resemble the histopathology of the resected lung. 
The patient is alive and recurrence-free 28 months after the operation. 
Discussion 
Duodenal tumors occupy nearly one third of all gastrointestinal neoplasms, but their 
incidence is uncommon. Primary malignant neoplasms of the duodenum account for 
about only 0.3% of all malignancies of the gastrointestinal tract [1, 2]. Regarding 
secondary involvement, autopsy studies have shown that metastases of any type to the 
small bowel account for only 1–2% of all metastases [3]. It is difficult to know the true 
incidence of metastatic neoplasms in the duodenum because the duodenal metastasis is 
concealed in most studies of small intestinal secondaries as mentioned above, and it has 
been mainly published as single case reports. Although the most common site of  
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occurrence of duodenal tumors is the periampullary region, the duodenal neoplasm in 
our patient was located in the nonampullary region of the second portion of the 
duodenum, and the diagnosis of metastatic melanoma was only established by 
immunohistochemical study of the surgical specimen. 
MM arises from pigment cells in the skin and is well known to be an aggressive and 
lethal malignancy. Although only a small percentage of cutaneous malignancies are due to 
MM, it accounts for the vast majority of skin cancer-related deaths. Despite the fact that 
the primary melanoma lesion is completely excised in most cases, metastasis occurs in 
about one third of patients [4], and melanomas have a tendency to metastasize to any part 
of organs and sometimes metastasize long after diagnosis of the primary lesion. Their 
unpredictable behavior is the most exasperating feature of this malignancy. 
MM is the most common extraabdominal primary neoplasm to metastasize to the 
gastrointestinal tract, including the duodenum [5]. The abundant blood supply of the 
intestine may account for the predilection of melanoma to metastasize to the small 
intestine, but the correct diagnosis is seldom made preoperatively. There is a large 
discrepancy between the incidence of metastatic melanoma of the upper gastrointestinal 
tract reported pre and post mortem (4–8% vs. 40–60%) by several investigators [5, 6]. 
Capizzi and Donohue reported that 80% of duodenal metastases by melanoma were first 
diagnosed at surgery [7]. These findings seem to illustrate well the difficulty of diagnosing 
intestinal metastasis of melanoma. In most cases, the primary neoplasm has already been 
identified by the time the duodenal tumor is biopsied, and it helps to make the 
histological diagnosis of secondary involvement. Although our patient had a history of 
cutaneous MM, the nonpigmented duodenal neoplasm discovered 26 years after the 
diagnosis of MM did not immediately suggest a diagnosis of metastatic MM. 
Endoscopic examination of the duodenal neoplasm reveals a protuberant submucosal 
tumor, with ulceration at the tip as the lesion grows larger in many cases, and black 
pigmentation in typical metastatic melanoma. However, metastatic melanoma was not 
diagnosed preoperatively in our case despite histological examination with biopsy, and 
the diagnosis was established only by immunostaining of the surgical specimen. The 
complete lack of pigmentation and the impossibility of aggressive biopsy because of the 
strong tendency of the tumor to bleed uncontrollably and its fragility are suggested as 
reasons for the delay in diagnosis. The absence of pigmentation in a tumor can lead to 
misdiagnosis for MM. However, pigmentation is not a specific feature of metastases of 
MM even when the primary lesion is pigmented, and distant metastases tend to be less 
pigmented than the primary tumor [8, 9]. Although amelanosis is likely to be associated 
with multiple changes or abnormalities in the gene expression that results in a single 
phenotype, the precise underlying mechanism of amelanosis has not been determined. As 
has been described in several reports, discoloration in melanomas represents a change 
from melanocytes to poorly differentiated cells that no longer produce melanin and 
indicates rapid growth of the tumor [10, 11]. 
Immunohistochemical study is helpful in identifying metastases of melanoma, and in 
our case, immunostaining with HMB45 and Melan-A was conclusive in making the 
diagnosis of metastatic duodenal melanoma. However, no specific antibody is available to 
identify MM. A combination of antibodies should therefore be used to make an accurate 
diagnosis of melanoma. 
The virulence of MM in its metastatic pattern is quite evident by the diffuse 
involvement in multiple organ systems. Cutaneous melanoma metastasizes by several 
pathways, and one third of melanomas metastasize to distant sites without first  
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metastasizing to any intermediate sites. In our patient, isolated pulmonary metastasis and 
duodenal metastasis occurred at different times, 18 and 26 years, respectively, after the 
initial diagnosis of cutaneous melanoma. To the best of our knowledge, the distant 
metastatic melanoma 26 years after the diagnosis of primary cutaneous lesion is the most 
delayed incidence as a detailed case report. 
Although there were long periods of tumor cell dormancy before the metastasis 
emerged in either organ, melanoma cells may have spread via blood vessels during 
repeated surgical treatment for relapses. The subtype of the MM in our patient was 
lentigo maligna, also known as ‘mélanome de Dubreuil’, which is a precursor lesion of 
lentigo maligna melanoma [12, 13]. Lentigo maligna melanoma is an invasive type of 
lentigo maligna that progresses by growing vertically beyond the dermal-epidermal 
junction. Lentigo maligna is known to have a strong tendency to repeatedly recur as in 
our case. Most recurrences do not pose an immediate threat to the patient’s life, but 
residual lesions as a result of inadequate treatment or atypical melanocytes that are 
resistant to destructive therapy may develop into invasive melanoma during the course of 
repeated excisions. In our case the initial lesion seems to have become an invasive 
melanoma and undergone gradual changes in features during the course of repeated 
surgical treatment. MM can give rise to distant metastases any time after the initial 
diagnosis of the primary lesion irrespective of previous sites of metastasis. 
Patients with stage IV melanoma have a very poor prognosis, and only a few of them 
survive beyond one year (median survival 4 to 9 months [14]). Although systemic 
therapeutic strategies, including chemotherapy and immunotherapy, have been 
developed, they have only succeeded in delaying the development of metastasis in a few 
cases, and there has been no proof of significant prolongation of survival. Surgery for 
stage IV melanoma is also considered palliative treatment for salvage from 
life-threatening complications. However, a considerable number of studies have shown a 
significant impact of surgical interventions on the survival rate in selected cases [15]. 
Several investigators have identified predictors of survival in patients with distant 
metastasis by melanoma: (1) location of the metastasis, (2) number of metastatic lesions, 
(3) disease-free interval since initial treatment of the primary lesion, and (4) serum lactate 
dehydrogenase level [4, 16]. Despite recurrence of MM six times at the primary cutaneous 
site in our case, the pulmonary and duodenal metastases occurred in isolation, and there 
were long disease-free intervals before metastasis to both organs. These favorable 
conditions appear to have led to the long survival time of our patient and support 
aggressive surgical management, and we have concluded that complete resection can lead 
to cure of this fatal malignancy in certain cases. In fact, the ability to perform a complete 
resection is the only treatment-related prognostic factor. Surgery should be performed to 
treat visceral metastasis not only for salvage from life-threatening conditions, such as 
intestinal obstruction, but to achieve a complete cure under certain conditions. 
In conclusion, it should be borne in mind that distant metastasis of MM can occur at 
any time, even long after the diagnosis of the primary lesion. Furthermore, it is important 
to note that metastases of melanomas tend to become amelanotic. When only one organ 
is involved by metastasis and complete surgical resection of the metastatic lesion is 
possible, aggressive surgical resection should remain a viable treatment option. Complete 
resection is very likely to provide long-term disease-free survival in selected cases. 
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Fig. 1. Endoscopic view of the duodenum. a No lesion was detected 3 months before. b Protuberance 
with smooth surface resulted in severe stenosis in the descending duodenum. 
 
 
 
Fig. 2. Abdominal computed tomography scan showing a large mass measuring 26 × 60 mm, extending 
vertically in the second portion of the duodenum. The protrusion into the lumen caused severe 
narrowing of the duodenal lumen. 
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Fig. 3. Photomicrograph of a histological section of the resected duodenal specimen. a Proliferation of 
tumor cells in the submucosal layer under an intact duodenal mucosa (H&E, original magnification 
×40). b The tumor exhibited an epithelioid pattern with large polygonal nonadherent cells containing 
abundant nonpigmented cytoplasms, and nuclei containing large nucleoli, and there were numerous 
mitoses (H&E, original magnification ×200). c Melanoma cells that stained positive immunohisto-
chemically (HMB45, original magnification ×400). d Melanoma cells that stained positive for Melan-A 
(Melan-A, original magnification ×400). 
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